20 Microns Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 10:17 pm

Market Cap	806 Cr.
Current Price	228
High / Low	348/158
Stock P/E	12.6
Book Value	122
Dividend Yield	0.55 %
ROCE	19.2 %
ROE	16.3 %
Face Value	5.00
PEG Ratio	0.57

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for 20 Microns Ltd

Competitors of 20 Microns Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Ganesha Ecoverse Ltd	85.9 Cr.	34.9	62.6/0.00		22.0	0.00 %	2.55 %	4.62 %	10.0
Foundry Fuel Products Ltd	5.30 Cr.	6.61	12.2/4.83		1.55	0.00 %	%	%	10.0
Deccan Gold Mines Ltd	2,151 Cr.	137	179/85.3		15.4	0.00 %	21.1 %	14.5 %	1.00
Asi Industries Ltd	297 Cr.	33.0	65.9/27.3	11.7	39.1	1.05 %	10.6 %	7.54 %	1.00
Anmol India Ltd	101 Cr.	17.7	38.5/14.0	14.4	18.9	0.00 %	9.83 %	6.72 %	10.0
Industry Average	38,783.71 Cr	571.84		21.43	93.34	1.68%	19.30%	16.68%	5.18

All Competitor Stocks of 20 Microns Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	172	186	188	155	173	191	200	175	212	231	240	215	227
Expenses	150	161	164	138	153	164	170	153	186	201	209	188	199
Operating Profit	22	25	23	17	21	26	30	22	27	30	31	26	29
OPM %	13%	13%	12%	11%	12%	14%	15%	13%	12%	13%	13%	12%	13%
Other Income	1	1	1	1	0	1	0	0	1	2	1	1	-0
Interest	4	4	5	4	4	4	4	4	5	4	4	5	5
Depreciation	4	3	3	3	4	3	3	4	4	4	5	5	5
Profit before tax	15	18	16	10	13	20	22	15	19	24	23	17	19
Tax %	27%	25%	26%	27%	29%	25%	28%	25%	29%	26%	27%	23%	20%
Net Profit	11	13	12	7	9	15	16	12	14	18	16	13	15
EPS in Rs	3.01	3.76	3.36	2.09	2.64	4.23	4.54	3.25	3.87	5.06	4.65	3.65	4.31

Last Updated: May 31, 2025, 9:59 am

Below is a detailed analysis of the quarterly data for 20 Microns Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 227.00 Cr.. The value appears strong and on an upward trend. It has increased from 215.00 Cr. (Dec 2024) to 227.00 Cr., marking an increase of 12.00 Cr..
For Expenses, as of Mar 2025, the value is 199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Dec 2024) to 199.00 Cr., marking an increase of 11.00 Cr..
For Operating Profit, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Dec 2024) to 29.00 Cr., marking an increase of 3.00 Cr..
For OPM %, as of Mar 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 13.00%, marking an increase of 1.00%.
For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
For Interest, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
For Depreciation, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
For Profit before tax, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Dec 2024) to 19.00 Cr., marking an increase of 2.00 Cr..
For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 23.00% (Dec 2024) to 20.00%, marking a decrease of 3.00%.
For Net Profit, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 4.31. The value appears strong and on an upward trend. It has increased from 3.65 (Dec 2024) to 4.31, marking an increase of 0.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 10:51 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	327	356	357	392	427	480	529	484	613	702	777	913
Expenses	297	326	310	337	367	411	463	425	534	616	672	796
Operating Profit	31	30	46	56	60	69	66	59	79	86	106	117
OPM %	9%	8%	13%	14%	14%	14%	12%	12%	13%	12%	14%	13%
Other Income	2	4	4	2	1	2	3	2	2	3	2	2
Interest	24	27	25	24	22	22	22	25	20	18	16	18
Depreciation	11	11	10	10	10	10	13	14	14	14	14	18
Profit before tax	-2	-3	14	23	28	38	35	22	48	57	77	83
Tax %	19%	-16%	24%	31%	32%	35%	30%	-6%	27%	27%	27%	24%
Net Profit	-2	-2	11	16	19	25	24	23	35	42	56	62
EPS in Rs	-0.68	-0.74	3.11	4.49	5.34	7.08	6.84	6.51	9.80	11.85	15.89	17.68
Dividend Payout %	0%	0%	0%	0%	14%	0%	9%	0%	0%	6%	8%	7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	0.00%	650.00%	45.45%	18.75%	31.58%	-4.00%	-4.17%	52.17%	20.00%	33.33%	10.71%
Change in YoY Net Profit Growth (%)	0.00%	650.00%	-604.55%	-26.70%	12.83%	-35.58%	-0.17%	56.34%	-32.17%	13.33%	-22.62%

20 Microns Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	10%
5 Years:	12%
3 Years:	14%
TTM:	17%

Compounded Profit Growth
10 Years:	36%
5 Years:	21%
3 Years:	23%
TTM:	11%

Stock Price CAGR
10 Years:	22%
5 Years:	48%
3 Years:	50%
1 Year:	4%

Return on Equity
10 Years:	15%
5 Years:	16%
3 Years:	17%
Last Year:	16%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:35 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	17	17	18	18	18	18	18	18	18	18	18	18
Reserves	57	54	70	107	126	150	170	197	234	276	335	412
Borrowings	177	165	163	152	134	124	119	104	123	108	121	165
Other Liabilities	77	98	83	86	98	112	137	133	140	121	114	120
Total Liabilities	328	333	334	363	376	404	444	452	514	523	588	715
Fixed Assets	158	151	151	177	185	195	201	203	207	213	212	284
CWIP	9	7	4	7	8	4	11	3	5	8	12	9
Investments	1	1	1	2	3	4	2	6	9	9	17	25
Other Assets	160	174	178	177	179	201	230	240	293	293	347	396
Total Assets	328	333	334	363	376	404	444	452	514	523	588	715

Below is a detailed analysis of the balance sheet data for 20 Microns Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
For Reserves, as of Mar 2025, the value is 412.00 Cr.. The value appears strong and on an upward trend. It has increased from 335.00 Cr. (Mar 2024) to 412.00 Cr., marking an increase of 77.00 Cr..
For Borrowings, as of Mar 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 121.00 Cr. (Mar 2024) to 165.00 Cr., marking an increase of 44.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Mar 2024) to 120.00 Cr., marking an increase of 6.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 715.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 588.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 127.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 284.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2024) to 284.00 Cr., marking an increase of 72.00 Cr..
For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 3.00 Cr..
For Investments, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 8.00 Cr..
For Other Assets, as of Mar 2025, the value is 396.00 Cr.. The value appears strong and on an upward trend. It has increased from 347.00 Cr. (Mar 2024) to 396.00 Cr., marking an increase of 49.00 Cr..
For Total Assets, as of Mar 2025, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 588.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 127.00 Cr..

Notably, the Reserves (412.00 Cr.) exceed the Borrowings (165.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	37	30	25	44	61	53	45	52	35	63	54	32
Cash from Investing Activity +	-21	-4	-6	-9	-18	-19	-16	-9	-23	-18	-23	-63
Cash from Financing Activity +	-14	-21	-26	-34	-44	-33	-30	-45	-4	-38	-3	14
Net Cash Flow	1	6	-6	2	-1	2	-1	-2	9	8	28	-17

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-146.00	-135.00	-117.00	-96.00	-74.00	-55.00	-53.00	-45.00	-44.00	-22.00	-15.00	-48.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	62	65	51	57	56	57	53	57	68	60	51	59
Inventory Days	111	134	126	150	133	132	134	128	144	148	115	99
Days Payable	76	112	138	118	105	113	106	115	134	113	79	54
Cash Conversion Cycle	96	87	39	90	84	77	80	69	78	94	87	104
Working Capital Days	55	47	47	72	66	59	60	63	73	86	78	88
ROCE %	15%	10%	9%	16%	18%	19%	21%	19%	15%	19%	19%	22%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	44.83%	44.83%	44.83%	44.83%	44.83%	44.83%	44.83%	44.95%	44.95%	44.95%	44.95%	44.99%
FIIs	0.46%	1.07%	0.70%	1.02%	0.73%	0.93%	0.72%	0.72%	0.72%	0.73%	0.78%	1.00%
DIIs	0.00%	0.00%	0.00%	0.13%	0.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.02%
Public	54.71%	54.10%	54.47%	54.03%	54.31%	54.23%	54.45%	54.33%	54.33%	54.32%	54.21%	53.99%
No. of Shareholders	18,259	25,064	23,759	23,011	22,444	22,336	22,332	19,768	20,546	22,492	26,057	31,992

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	15.89	11.85	9.80	6.51	6.83
Diluted EPS (Rs.)	15.89	11.85	9.80	6.51	6.83
Cash EPS (Rs.)	19.94	15.78	13.72	10.44	10.40
Book Value[Excl.RevalReserv]/Share (Rs.)	100.35	83.50	71.53	60.99	53.43
Book Value[Incl.RevalReserv]/Share (Rs.)	100.35	83.50	71.53	60.99	53.43
Revenue From Operations / Share (Rs.)	220.34	198.85	173.78	137.03	150.01
PBDIT / Share (Rs.)	30.95	25.13	23.11	17.29	19.44
PBIT / Share (Rs.)	26.88	21.22	19.24	13.37	15.89
PBT / Share (Rs.)	21.77	16.18	13.50	6.17	9.79
Net Profit / Share (Rs.)	15.87	11.87	9.85	6.52	6.85
NP After MI And SOA / Share (Rs.)	15.89	11.85	9.80	6.51	6.83
PBDIT Margin (%)	14.04	12.63	13.29	12.62	12.95
PBIT Margin (%)	12.19	10.66	11.07	9.76	10.59
PBT Margin (%)	9.88	8.13	7.76	4.50	6.52
Net Profit Margin (%)	7.20	5.96	5.66	4.75	4.56
NP After MI And SOA Margin (%)	7.21	5.95	5.64	4.75	4.55
Return on Networth / Equity (%)	15.88	14.24	13.75	10.71	12.84
Return on Capital Employeed (%)	23.69	21.75	21.90	17.79	21.36
Return On Assets (%)	9.50	7.98	6.71	5.07	5.42
Long Term Debt / Equity (X)	0.03	0.06	0.11	0.11	0.20
Total Debt / Equity (X)	0.32	0.34	0.47	0.40	0.55
Asset Turnover Ratio (%)	1.40	1.23	1.14	1.02	1.22
Current Ratio (X)	1.75	1.53	1.33	1.23	1.19
Quick Ratio (X)	1.16	0.88	0.70	0.68	0.65
Inventory Turnover Ratio (X)	3.65	2.92	2.85	2.63	3.34
Dividend Payout Ratio (NP) (%)	4.72	0.00	0.00	0.00	8.77
Dividend Payout Ratio (CP) (%)	3.75	0.00	0.00	0.00	5.77
Earning Retention Ratio (%)	95.28	0.00	0.00	0.00	91.23
Cash Earning Retention Ratio (%)	96.25	0.00	0.00	0.00	94.23
Interest Coverage Ratio (X)	6.63	4.99	4.03	2.40	3.19
Interest Coverage Ratio (Post Tax) (X)	4.50	3.36	2.72	1.90	2.12
Enterprise Value (Cr.)	563.53	334.96	365.34	200.94	187.26
EV / Net Operating Revenue (X)	0.72	0.47	0.59	0.41	0.35
EV / EBITDA (X)	5.16	3.78	4.48	3.29	2.73
MarketCap / Net Operating Revenue (X)	0.65	0.37	0.42	0.25	0.17
Retention Ratios (%)	95.27	0.00	0.00	0.00	91.22
Price / BV (X)	1.44	0.89	1.04	0.57	0.48
Price / Net Operating Revenue (X)	0.65	0.37	0.42	0.25	0.17
EarningsYield	0.11	0.15	0.13	0.18	0.26

After reviewing the key financial ratios for 20 Microns Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
For Diluted EPS (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
For Cash EPS (Rs.), as of Mar 24, the value is 19.94. This value is within the healthy range. It has increased from 15.78 (Mar 23) to 19.94, marking an increase of 4.16.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.35. It has increased from 83.50 (Mar 23) to 100.35, marking an increase of 16.85.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.35. It has increased from 83.50 (Mar 23) to 100.35, marking an increase of 16.85.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 220.34. It has increased from 198.85 (Mar 23) to 220.34, marking an increase of 21.49.
For PBDIT / Share (Rs.), as of Mar 24, the value is 30.95. This value is within the healthy range. It has increased from 25.13 (Mar 23) to 30.95, marking an increase of 5.82.
For PBIT / Share (Rs.), as of Mar 24, the value is 26.88. This value is within the healthy range. It has increased from 21.22 (Mar 23) to 26.88, marking an increase of 5.66.
For PBT / Share (Rs.), as of Mar 24, the value is 21.77. This value is within the healthy range. It has increased from 16.18 (Mar 23) to 21.77, marking an increase of 5.59.
For Net Profit / Share (Rs.), as of Mar 24, the value is 15.87. This value is within the healthy range. It has increased from 11.87 (Mar 23) to 15.87, marking an increase of 4.00.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
For PBDIT Margin (%), as of Mar 24, the value is 14.04. This value is within the healthy range. It has increased from 12.63 (Mar 23) to 14.04, marking an increase of 1.41.
For PBIT Margin (%), as of Mar 24, the value is 12.19. This value is within the healthy range. It has increased from 10.66 (Mar 23) to 12.19, marking an increase of 1.53.
For PBT Margin (%), as of Mar 24, the value is 9.88. This value is below the healthy minimum of 10. It has increased from 8.13 (Mar 23) to 9.88, marking an increase of 1.75.
For Net Profit Margin (%), as of Mar 24, the value is 7.20. This value is within the healthy range. It has increased from 5.96 (Mar 23) to 7.20, marking an increase of 1.24.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.21. This value is below the healthy minimum of 8. It has increased from 5.95 (Mar 23) to 7.21, marking an increase of 1.26.
For Return on Networth / Equity (%), as of Mar 24, the value is 15.88. This value is within the healthy range. It has increased from 14.24 (Mar 23) to 15.88, marking an increase of 1.64.
For Return on Capital Employeed (%), as of Mar 24, the value is 23.69. This value is within the healthy range. It has increased from 21.75 (Mar 23) to 23.69, marking an increase of 1.94.
For Return On Assets (%), as of Mar 24, the value is 9.50. This value is within the healthy range. It has increased from 7.98 (Mar 23) to 9.50, marking an increase of 1.52.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 23) to 0.03, marking a decrease of 0.03.
For Total Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has decreased from 0.34 (Mar 23) to 0.32, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.40. It has increased from 1.23 (Mar 23) to 1.40, marking an increase of 0.17.
For Current Ratio (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 1.53 (Mar 23) to 1.75, marking an increase of 0.22.
For Quick Ratio (X), as of Mar 24, the value is 1.16. This value is within the healthy range. It has increased from 0.88 (Mar 23) to 1.16, marking an increase of 0.28.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.92 (Mar 23) to 3.65, marking an increase of 0.73.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.72. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 4.72, marking an increase of 4.72.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.75. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 3.75, marking an increase of 3.75.
For Earning Retention Ratio (%), as of Mar 24, the value is 95.28. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.28, marking an increase of 95.28.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.25. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.25, marking an increase of 96.25.
For Interest Coverage Ratio (X), as of Mar 24, the value is 6.63. This value is within the healthy range. It has increased from 4.99 (Mar 23) to 6.63, marking an increase of 1.64.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.50. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 4.50, marking an increase of 1.14.
For Enterprise Value (Cr.), as of Mar 24, the value is 563.53. It has increased from 334.96 (Mar 23) to 563.53, marking an increase of 228.57.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.72, marking an increase of 0.25.
For EV / EBITDA (X), as of Mar 24, the value is 5.16. This value is within the healthy range. It has increased from 3.78 (Mar 23) to 5.16, marking an increase of 1.38.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 23) to 0.65, marking an increase of 0.28.
For Retention Ratios (%), as of Mar 24, the value is 95.27. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.27, marking an increase of 95.27.
For Price / BV (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.89 (Mar 23) to 1.44, marking an increase of 0.55.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 23) to 0.65, marking an increase of 0.28.
For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 23) to 0.11, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of 20 Microns Ltd as of June 26, 2025 is: 201.55

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 26, 2025, 20 Microns Ltd is Overvalued by 11.60% compared to the current share price 228.00

Intrinsic Value of 20 Microns Ltd as of June 26, 2025 is: 246.13

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 26, 2025, 20 Microns Ltd is Undervalued by 7.95% compared to the current share price 228.00

Last 5 Year EPS CAGR: 22.12%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 16.83%, which is a positive sign. The company has higher reserves (182.33 cr) compared to borrowings (137.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (529.75 cr) and profit (35.00 cr) over the years.	The stock has a high average Working Capital Days of 66.17, which may not be favorable. The stock has a high average Cash Conversion Cycle of 82.08, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 20 Microns Ltd:
1. Net Profit Margin: 7.2%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 23.69% (Industry Average ROCE: 19.3%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 15.88% (Industry Average ROE: 16.68%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.5
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.16
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 12.6 (Industry average Stock P/E: 21.43)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.32
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

20 Microns Ltd. is a Public Limited Listed company incorporated on 29/06/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC009768 and registration number is 009768. Currently Company is involved in the business activities of Mining/quarrying of limestone, limeshell, kankar' and other calcareous minerals including calcite, chalk and shale. Company's Total Operating Revenue is Rs. 794.92 Cr. and Equity Capital is Rs. 17.64 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Mining/Minerals	9/10, GIDC Industrial Estate, Waghodia, Vadodra District Gujarat 391760	co_secretary@20microns.com http://www.20microns.com

Management
Name	Position Held
Mr. Rajesh C Parikh	Chairman & Managing Director
Mr. Atil C Parikh	Managing Director & CEO
Mrs. Sejal R Parikh	Whole Time Director
Mr. Ramkisan A Devidayal	Independent Director
Mr. Atul H Patel	Independent Director
Dr. Ajay I Ranka	Independent Director
Mr. Jaideep B Verma	Independent Director
Dr. Sivaram Swaminathan	Addnl.Independent Director
Mr. Dukhabandhu Rath	Independent Director

FAQ

What is the intrinsic value of 20 Microns Ltd?

20 Microns Ltd's intrinsic value (as of 25 June 2025) is ₹201.55 — 11.60% lower the current market price of 228.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 806 Cr. market cap, FY2025-2026 high/low of ₹348/158, reserves of 412 Cr, and liabilities of 715 Cr.

What is the Market Cap of 20 Microns Ltd?

The Market Cap of 20 Microns Ltd is 806 Cr..

What is the current Stock Price of 20 Microns Ltd as on 25 June 2025?

The current stock price of 20 Microns Ltd as on 25 June 2025 is 228.

What is the High / Low of 20 Microns Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of 20 Microns Ltd stocks is ₹348/158.

What is the Stock P/E of 20 Microns Ltd?

The Stock P/E of 20 Microns Ltd is 12.6.

What is the Book Value of 20 Microns Ltd?

The Book Value of 20 Microns Ltd is 122.

What is the Dividend Yield of 20 Microns Ltd?

The Dividend Yield of 20 Microns Ltd is 0.55 %.

What is the ROCE of 20 Microns Ltd?

The ROCE of 20 Microns Ltd is 19.2 %.

What is the ROE of 20 Microns Ltd?

The ROE of 20 Microns Ltd is 16.3 %.

What is the Face Value of 20 Microns Ltd?

The Face Value of 20 Microns Ltd is 5.00.